Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy

Ítems similars

• Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
  per: Ulldemolins, Marta, et al.
  Publicat: (2015)
• Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children
  per: Aygün, Fatih, et al.
  Publicat: (2019)
• Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
  per: Lewejohann, J-C, et al.
  Publicat: (1999)
• Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
  per: Seyler, Lucie, et al.
  Publicat: (2011)
• Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
  per: Taccone, Fabio Silvio, et al.
  Publicat: (2010)